The USA, Hemp Law, and Cannabis Seeds: Why the new seed clause suddenly makes Europe more important

The USA is redrawing the lines for hemp. What Public Law 119-37, H.R. 9830, and the seed question could mean for breeders, seed banks, preservation, and the European genetics market.

For years, cannabis seeds were an astonishing legal construct in the USA.

The plant that could grow from them could be prohibited as marijuana under federal law.

The seed itself, however, could:

Be hemp.

Not because nobody knew what genetic potential lay within them.

But because federal law looked at the chemical composition of the material itself.

A seed of modern THC-rich genetics typically contains only minimal amounts of Delta-9-THC. That is precisely why many cannabis seeds could fall outside the Controlled Substances Act under the hemp definition of the 2018 Farm Bill.

In 2026, this principle is suddenly up for debate.

Not through a classic cannabis ban.

Not through a dedicated seed ban bill.

But through a few lines in the definition of an entirely different legal area:

Hemp.

And those exact lines could reach far beyond American cannabinoid products.

The seed was federally different from its subsequent plant

The crucial starting point lies in the Agriculture Improvement Act of 2018, better known as the Farm Bill.

With it, the US Congress removed hemp from the federal definition of marijuana.

The decisive factor was:

no more than 0.3% Delta-9-THC based on dry weight.

The definition expressly included seeds.

This led to a remarkable consequence.

A cannabis seed could contain less than 0.3% Delta-9-THC and thus be hemp under federal law – regardless of whether its genetics could later produce a plant that far exceeds this limit.

The DEA confirmed this interpretation in 2022 in response to legal inquiries. In the well-known statement dated January 6, the agency declared that marijuana seeds with no more than 0.3% Delta-9-THC meet the hemp definition and therefore do not fall under the Controlled Substances Act. A further DEA response in December 2022 confirmed the same fundamental position for seeds and other genetic material.

The classification is important:

These DEA letters were official legal opinions, not a Supreme Court ruling or a specific seed legalization by Congress.

Nevertheless, they created a crucial federal reference point for the American genetics market.

A legal detail became infrastructure

The effect was greater than the wording suggests.

American breeders were no longer exclusively dependent on moving genetic material within individual state cannabis systems.

Under the hemp interpretation, seeds could enter a national market much more easily under federal law.

And numerous other regions could be genetically more closely connected.

Of course, other rules remained in place.

States have their own cannabis laws. Seeds are additionally subject to general regulations. Import and export, in turn, have their own phytosanitary and customs levels.

Federal hemp therefore never meant:

completely unregulated everywhere and for every purpose.

But the seed had a crucial advantage: it did not automatically have to have the same federal status as the THC-rich plant that could later grow from it.

That exact principle is now being challenged.

Public Law 119-37 changes the definition

On November 12, 2025, Public Law 119-37 was signed.

Section 781 comprehensively changes the federal definition of hemp.

The political debate behind it was aimed strongly at the market for intoxicating hemp products that had emerged since the Farm Bill – including products with Delta-8-THC, THCA, and various chemically produced or modified cannabinoids.

But the law’s text goes beyond finished cannabinoid products.

In the future, hemp will basically be based on:

Total THC including THCA

and defined accordingly.

And even more importantly for genetics:

The text contains, for the first time, an explicit exclusion for viable seeds.

According to this, no hemp shall be a viable Cannabis sativa L. seed if the plant from which this seed originates has more than 0.3% total THC including THCA on a dry-weight basis.

This is exactly where the logic changes.

No longer just: what is chemically in the seed?

Under the previous DEA interpretation, the key was:

How much Delta-9-THC does this genetic material itself contain?

The new clause asks something different for viable seeds:

Which plant does this seed come from?

That is a fundamental difference.

Because for seeds of modern THC-oriented cannabis genetics, the low THC level of the seed is not the problem.

It is the origin.

If the viable seed comes from a plant that exceeds the new total THC limit, it would expressly fall out of the hemp category under the new definition. The Congressional Research Service describes this change accordingly as an exclusion of such seeds from the hemp definition.

With that, the seed loses the exact special federal status upon which a part of the modern American seed market was based.

That is more than semantics

Why is the hemp definition so important at all?

Because hemp is exempted under federal law from the marijuana regime of the Controlled Substances Act.

If a cannabis product no longer falls under the hemp exemption, the question regarding the Controlled Substances Act becomes relevant again.

The Congressional Research Service expressly points out that the newly excluded products would no longer be treated as hemp after taking effect and could therefore fall under the federal marijuana regime.

Therefore, it would be too weak to represent the change only as a new labeling problem.

For affected viable seeds, their federal classification can change.

So is this the great US seed ban?

Not so fast.

"Seed ban" is an excellent headline.

Legally, it is too broad.

The new rule does not mean:

All cannabis seeds are banned.

The actual problem primarily concerns a structure that has been exceptionally important until now:

the trade in germinable THC-oriented cannabis genetics, which has been treated more leniently under federal law.

That is precisely where the new boundary can create significant friction.

And then came September 2026

Originally, Section 781 was supposed to take effect 365 days after the signing of Public Law 119-37.

That is, on:

November 12, 2026.

Then came H.R. 6500.

President Trump signed the Continuing Appropriations and Extensions Act, 2027 on September 2, 2026; the law is now numbered Public Law 119-103.

Section 2019 is contained within it.

And this one passage has changed the timeline once again.

The November deadline wasn't just postponed

Here, legal precision pays off.

Section 2019 does not say:

Section 781 only comes into effect on December 11.

Instead, the provision stipulates that the amendments from Section 781 shall only apply to two expressly designated categories until December 11, 2026. This concerns products with cannabinoids that a cannabis sativa plant cannot produce naturally.

The exclusion for germinable seeds is not one of these two prematurely covered categories.

Practically speaking, this means for the seed scene:

The application of the new seed clause, which was originally looming for November 12, is being held back for this short window of time.

The scene has been granted additional time. But not a permanent solution.

The next cliff is in mid-December

If Congress does not change anything else by then, this temporary limitation will lapse after December 11.

Then the broader Section 781 structure would apply – including the exclusion of germinable seeds derived from cannabis plants exceeding the 0.3% total THC limit.

This is exactly why December is now more important than the original November deadline.

But even this deadline is not a law of nature.

Congress can act again.

And a concrete counterproposal is already on the table.

H.R. 9830: the Lawful Hemp Protection Act

On July 22, 2026, Republican Representative Andy Barr of Kentucky and Democratic Representative Angie Craig of Minnesota introduced the Lawful Hemp Protection Act – H.R. 9830.

That is remarkable.

Not only because the bill was introduced on a bipartisan basis.

But because it would correct the seed issue at its very core.

Regarding germinable seeds, H.R. 9830 stipulates:

The mother plant should not be the deciding factor.

Instead, once again:

the seed itself.

According to the bill, a seed would only fall out of the hemp definition if the seed itself contains more than 1% total THC on a dry weight basis.

With that, the principle would return to its core, to where it stood before Public Law 119-37:

Judge material by what is chemically contained within it – not by the potential of its genetics.

But H.R. 9830 is larger than the seed issue

Within the seed scene, the bill is understandably being discussed as a potential seed fix.

In fact, it goes much further.

H.R. 9830 would raise the general hemp definition to 1% total THC, create a new regulatory system for hemp-derived cannabinoid products, and repeal Section 781 of Public Law 119-37.

The seed rule is therefore part of a significantly more comprehensive political counter-model.

And:

The bill is not yet a law.

As of September 10, 2026, H.R. 9830 has only been introduced in the House and referred to several committees. The most recently documented parliamentary action dates back to July 22.

There is a political way out.

There is no guarantee yet.

That is exactly why the economic uncertainty is already real today

A law does not need to lead to thousands of seizures to change a market.

Businesses operate with risk.

When a business model transitions federally from:

relatively clearly treatable as hemp

to:

possibly marijuana under federal law

the uncertainty alone can have economic consequences.

This especially affects smaller breeders.

Large companies can fund legal advice, multiple entities, warehouse locations, and more complex distribution structures.

A small breeder shipping seeds directly to a national community often does not possess this infrastructure.

What could actually happen?

No one can seriously predict what the American genetics market will look like after December.

But some structural scenarios are plausible.

These are possible economic reactions, not already decided consequences.

But that is precisely where the European dimension lies.

Because cannabis seeds are not ordinary goods

A seed pack is not just inventory.

It contains:

genetics.

A plant population can preserve characteristics that were selected years ago.

Certain parents disappear. Cuts are lost. Breeders quit. Seed lots are not reproduced. Populations change over generations.

And sometimes, a certain genetic branch eventually only exists in private refrigerators and old packs.

The Cannaseuse page on seed banks and cannabis genetics covers exactly this difference between a name on a package and documentable lineage.

Therefore, when political rules make the exchange of genetic material more difficult, it affects more than short-term availability.

It can influence in the long term where genetics are maintained, reproduced, and further developed.

And suddenly, Europe becomes strategically more interesting

Modern genetics culture has looked very strongly toward the USA over the past ten to fifteen years.

The American scene – especially California, but by no means only California – has enormously shaped modern cannabis aesthetics, breeding, and marketing.

The Cannaseuse article on US cannabis culture and genetics shows exactly this development: America turned breeders, cuts, pheno hunts, and lineages into a part of cultural identity.

In the process, Europe increasingly became an importer of American trends.

Yet Europe itself possesses a seed history spanning decades.

Amsterdam was a genetics hub before Cali was a buzzword for quality

The Netherlands became a crucial center for modern cannabis seeds as early as the 1980s and 1990s.

Seed banks collected international genetics.

Afghan, Thai, Colombian, Mexican, and American influences were combined with one another.

Amsterdam became the meeting point for breeders and growers from various countries.

Names that are still active today serve as a reminder of this.

Green House Seed Company represents this Amsterdam legacy perspective.

Dutch Passion has been working within this European seed bank tradition since the 1980s.

Modern cannabis genetics culture didn't just start with a Mylar bag from Los Angeles.

Spain became the next important European stage

Later, Spain—specifically Barcelona—developed into another hub.

Today, it is home not only to classic Spanish seed banks but also to boutique projects with strong connections to modern American genetics.

Perfect Tree Seeds is a good example: Barcelona DNA meets modern Z, Kush, Sherbert, and Fruit families.

Sweet Seeds, in turn, demonstrates a different European evolution—from early feminized genetics to autoflower and "Fast Version" projects, all the way to current US-inspired hybrids.

So, genetically speaking, Europe is far from a blank slate.

The opportunity lies in more than just distributing American packs

If direct shipping from America were to become more complicated, an initial reaction is obvious:

This could enable US breeders to serve the European market more effectively via European infrastructure.

For seed banks, supply chains could become more predictable.

For customers, certain genetics might remain available for longer.

But if Europe only becomes the next warehouse for American drops, the real opportunity would be seen as quite small.

More interestingly: Europe could return to breeding more itself

The more important question isn't:

How do we keep getting every new US genetic?

But rather:

Why shouldn't the next internationally defining cannabis family come from Europe again?

Europe possesses cannabis lines preserved for decades, experienced breeders, a large grower community, highly diverse climate zones, seed bank infrastructure, and its own cultural history.

What the US has often succeeded at better in recent years is something else:

Making breeding visible.

Europe can adopt exactly this culture without having to copy American branding mechanics.

Less "Cali-copying" could be Europe's advantage

The modern seed market possesses a strange form of diversity.

Hundreds of new names.

But beneath them, the same families appear over and over again.

This can produce excellent genetics.

But a hundred different names don't automatically mean a hundred genetically distinct populations.

A European counter-movement could therefore be more interesting: preserve old European work, look for less overused parents, document regional selections, integrate modern US cuts meaningfully, but juxtapose them with a unique signature.

Not:

Europe versus USA.

But rather:

Europe alongside USA.

And Germany?

Since 2024, Germany has been in an unusual starting position.

The KCanG treats seeds and cuttings as propagation material and explicitly excludes propagation material from the legal definition of cannabis. Section 4 generally permits the handling of cannabis seeds, provided they are not intended for illicit cultivation.

Additionally, adults are allowed to privately cultivate up to three cannabis plants at their place of residence or usual abode for personal consumption.

However, another sentence is particularly relevant to the international seed question.

For private or communal personal cultivation, Section 4 of the KCanG permits the import of cannabis seeds only from member states of the European Union.

Consequently, the EU internal market already holds special legal significance for German growers today.

This makes Europe structurally more important for Germany

Anyone in Germany obtaining seeds for private home growing from abroad already has an expressly privileged region of origin with the EU.

The US falls outside this framework.

This is precisely why a stronger European presence of American breeders would be strategically interesting for the German market:

Not necessarily as direct shipping from California.

But via legal European distribution structures and stocks located within the EU.

This does not mean that every conceivable US genetic can automatically be imported, reproduced, or distributed in Europe in a legally secure manner.

International movement of goods, commercial production, plant variety protection, trademark rights, seed law, and cannabis law remain separate layers.

But the direction is clear:

For the German seed market, European infrastructure is already more important than American direct logistics.

Germany is still not a "free" breeder market, however

One shouldn't get ahead of themselves here.

Private homegrowing does not automatically mean:

commercial cannabis cultivation is free.

The KCanG explicitly defines private cultivation as non-commercial cultivation for personal consumption.

Professional breeding, production of large quantities of seeds, cannabis cultivation for commercial breeding purposes, import and export of plant material, or transfer outside the intended legal structures can trigger other legal issues.

Therefore, the statement:

Now German growers can simply become professional breeders.

is false.

But what has actually changed is:

A great many more people can legally engage with cannabis genetics.

You can observe different genetics, compare phenotypes, learn about pedigrees, and understand the differences between breeders.

And this builds genetic competence within the community.

Culturally, this is the prerequisite for the long-term development of more professional structures—provided the legal framework is in place.

The German seed market is becoming more sophisticated as a result

At the beginning of a new grower generation, this is often enough:

feminized or auto?

Later on, the questions change.

This is a natural maturation process.

And it is changing the seed market.

The Cannaseuse article on cannabis cultivars explains exactly why a named strain should not automatically be equated with genetic uniformity.

The more experienced the community becomes, the less a famous name alone suffices.

This is where Europe’s real opportunity lies

America has given modern cannabis genetics something decisive:

Visibility.

Breeders became personas. Cuts became stories. Pheno hunts became content. Genetic families became part of pop culture. Cannabis seeds became collectibles.

This was immensely effective.

But the same development also revealed its dark side.

Europe has the rare opportunity to learn from both sides at the same time.

Preservation could become more important again

When genetics can no longer travel as easily across countries and states, an old task suddenly gains renewed significance:

Preservation.

Not every historical cultivar exists forever.

Not every cut stays healthy. Not every seed lot is produced again. Not every breeder is still working with the same parents ten years later.

Therefore, preservation does not mean nostalgically collecting old packs.

It means maintaining and documenting genetic diversity in a traceable way.

This is less spectacular than a new drop.

In the long run, it may be significantly more important.

Origin could become more important than hype again

Perhaps this is exactly the larger consequence of the American debate.

Not:

USA disappears. Europe takes over.

That is not how genetics work.

The USA will remain a decisive hub for modern cannabis breeding even with stricter federal seed regulations.

California, Oregon, Michigan, Colorado, and other markets possess enormous experience, genetic material, professional production, and cultural influence.

But an international scene that depends too heavily on a single country remains vulnerable.

And suddenly, the importance of decentralized genetics infrastructure becomes visible.

Europe doesn’t need to become the next California

Perhaps that would even be the most boring development possible.

Europe has other stories.

All of this doesn’t need to be put into American packaging to be relevant.

The Cannaseuse article on cannabis in Berlin, for example, shows that Germany itself already has its own cannabis history, long before home growing became legally possible in 2024.

The next genetics culture can build on that.

The USA is redrawing the line – but the story is still open

As of September 10, 2026, none of this is final.

Because of this, things could change again in the coming months.

This is exactly why one should neither prematurely declare the American seed market dead nor dismiss the debate as unimportant.

Because even if Congress eventually softens the seed rule, the discussion has already made something visible:

Genetics need infrastructure.

FAQ: USA, Hemp Law, and Cannabis Seeds

Conclusion: Europe's opportunity does not start with an American ban

Perhaps the big turning point will come in December.

Perhaps Congress will change the rule before then.

Perhaps H.R. 9830 or another compromise will prevail.

Perhaps a completely different solution will emerge in the end.

That remains open.

What is not open:

The last few years have produced an international genetics culture that is exceptionally heavily influenced by the USA.

And yet, Europe still possesses its own tradition of seed banks, growers, and breeding.

The American debate is therefore less of a reason to hope for a collapse of the US market.

It is a catalyst to think about resilience.

Germany has a special role here: The KCanG [Cannabis Act] has legally separated seeds from the definition of cannabis and expressly defined the EU region as a permissible import source for private homegrowing. At the same time, professional cannabis cultivation remains legally something entirely different from private homegrowing. It is precisely this boundary that should be taken seriously.

Europe does not need to replace America for this reason.

And it shouldn't try to, either.

A more exciting development would be an international genetics scene with several strong hubs.

California and Barcelona.

Oregon and Amsterdam.

Michigan and Valencia.

And perhaps one day:

Berlin.

Not because politics creates good genetics.

But because political uncertainty sometimes makes it visible where structures are missing.

Note: This article describes the political and legal status as of September 10, 2026, and does not constitute legal advice. American hemp legislation is currently developing rapidly; additional national and international regulations apply to commercial import, export, seed production, or breeding.